These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8917914)

  • 1. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
    Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
    Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow.
    Rhodes TJ; Bloor MJ; Donoghoe MC; Haw S; Ettore B; Platt S; Frischer M; Hunter GM; Taylor A; Finlay A
    AIDS Care; 1993; 5(4):413-25. PubMed ID: 8110856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk behaviour, anti-HIV and anti-hepatitis B core prevalence in clinic and non-clinic samples of gay men in England, 1991-1992.
    Hart GJ; Dawson J; Fitzpatrick RM; Boulton M; McLean J; Brookes M; Parry JV
    AIDS; 1993 Jun; 7(6):863-9. PubMed ID: 8363762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk behaviors for HIV transmission among the recent clients of a syringe-exchange program in Madrid, 1993].
    Bravo Portela MJ; Barrio Anta G; de la Fuente de Hoz L; Colomo Gómez C; Royuela Morales L; Estébanez Estébanez P
    Gac Sanit; 1996; 10(57):261-73. PubMed ID: 9072510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus, human immunodeficiency virus type-1, and syphilis among women attending prenatal clinics in Belize, Central America.
    Scott-Wright A; Hakre S; Bryan JP; Jaramillo R; Reyes LG; Cruess D; Macarthy PO; Gaydos JC
    Am J Trop Med Hyg; 1997 Mar; 56(3):285-90. PubMed ID: 9129530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
    Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
    Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HIV, hepatitis B and associated risk behaviours in clients of a needle-exchange in central London.
    Hart GJ; Woodward N; Johnson AM; Tighe J; Parry JV; Adler MW
    AIDS; 1991 May; 5(5):543-7. PubMed ID: 1863406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
    Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
    J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.
    Neaigus A; Gyarmathy VA; Miller M; Frajzyngier V; Zhao M; Friedman SR; Des Jarlais DC
    Drug Alcohol Depend; 2007 Jul; 89(2-3):234-43. PubMed ID: 17289298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
    Fuglsang T; Fouchard JR; Ege PP
    Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors.
    Gossop M; Griffiths P; Powis B; Williamson S; Fountain J; Strang J
    AIDS Care; 1997 Dec; 9(6):651-60. PubMed ID: 26672149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued risk behaviour among HIV positive drug injectors in London: implications for intervention.
    Rhodes TJ; Donoghoe MC; Hunter GM; Stimson GV
    Addiction; 1993 Nov; 88(11):1553-60. PubMed ID: 8287001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV testing and unreported HIV positivity among injecting drug users in London.
    Donoghoe MC; Rhodes TJ; Hunter GM; Stimson GV
    AIDS; 1993 Aug; 7(8):1105-11. PubMed ID: 8397948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
    Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.